📰 Merck Sharp News
Page 37 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
May 1, 2023
/PRNewswire/ -- DelveInsights Glioma Market Insights report includes a comprehensive understanding of current treatment practices, glioma emerging drugs,...
April 28, 2023
In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute’s Toni Choueiri, MD, researchers investigated for the first time the combination of cabozantinib, a VEGF TKI, plus belzutifan, a HIF-2α inhibitor.
April 28, 2023
Among nearly 1 in 4 patients whose MRI results were initially positive for sacroiliitis, results were negative 6 weeks after NSAIDs were taken.
April 27, 2023
TME PHARMA ANNOUNCES NEW DATA FROM NOX-A12 GLORIA PHASE 1/2 STUDY IN GLIOBLASTOMA TO BE PRESENTED AT ASCO ANNUAL MEETING IN JUNE 2023 ... | April 27, 2023
April 27, 2023
Applications are open for early and growth-stage health tech innovators
April 27, 2023
Last November, we offered well-deserved criticisms of a really bad MDL-wide preemption decision in In re Acetaminophen − ASD-ADHD Products Liability…
April 27, 2023
Jakub G Sobiecki and team aim to develop a biomarker score able to discriminate between Mediterranean diet and habitual diet, and test its association with incident type 2 diabetes in a European cohort.
April 26, 2023
Applications are open for early and growth-stage health tech innovators
April 26, 2023
In a phase 2 trial, pembrolizumab produced an overall response rate of 89% in patients with unresectable desmoplastic melanoma.
April 25, 2023
Dr. Taiwo Olatunji is the Founder and Medical Director of Millennium Health Focus (MHF). Olatunji in this interview with The Guardian urged for more investment in Nigeria’s health sector and decried the challenges faced by Nigerian students in the United Kingdom...